Canaccord Genuity Upgrades Biogen (BIIB) to Buy
Tweet Send to a FriendGet Alerts BIIB Hot Sheet
Price: $232.62 -0.19%
Rating Summary:
17 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
17 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade BIIB Now!
Canaccord Genuity upgraded Biogen (NASDAQ: BIIB) from Hold to Buy with a price target of $187.00 (from $163.00).
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $161.99 yesterday, with a 52 week range of $114.53-$169.07.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $161.99 yesterday, with a 52 week range of $114.53-$169.07.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Biogen Idec (BIIB) Appoints Spyros Artavanis-Tsakonas as CSO
- Sidoti Upgrades Nordion Inc (NDZ) to Buy
- Sidoti Upgrades REX American Resources (REX) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
